Concord Enviro Systems Limited is bringing its initial public offering or IPO to raise Rs 500.33 crores from the primary market. The issue is a combination of fresh issue of 0.25 crore shares ...

Circle, USDC issuer, files for IPO on NYSE under ticker CRCL, offering 24M shares and rejecting acquisition rumors from ...

Concord Enviro Systems IPO: The initial public offering (IPO) of Concord Enviro Systems continued to witness a healthy response from investors on the final day of bidding. The IPO, which opened ...

Concord Enviro IPO: Apply or not? Concord Enviro Systems Limited, a global provider of water and wastewater treatment and reuse solutions, including zero-liquid discharge (ZLD) technology ...

Once Concord Enviro IPO allotment status becomes public, applicants can check their application status online by logging in at the BSE website or the official registrar, Link Intime India Private ...

“For Circle, becoming a publicly traded corporation on the New York Stock Exchange is a continuation of our desire to operate ...

Concord Biotech will finalize the basis of allotment on Friday The issue was open between August 4-8, sold between Rs 705-751 The company raised Rs 1,551 crore via IPO, listing on August 18 ...

A Rs 9 crore SME IPO gets bids worth over Rs 2,700 crore Finally, the much-awaited listing of equity shares will take place on the BSE and NSE on August 18. Concord Biotech shares were available ...

The initial public offering (IPO) of Concord Enviro Systems opens for bidding on December 19. The company shall be offering its shares in the range of Rs 665-701 per share. Investors can apply ...

Concord Biotech, backed by Rare Enterprises, is set to launch its initial public offering (IPO) on August 4, with a price band of Rs 705-741 ($9.45-$9.93) per share, aiming to raise Rs 15.5bn ($208m).

Concord Biotech, which manufactures Active Pharmaceutical Ingredients (API) through fermentation and semi-synthetic processes and finished formulations, has an issue size of Rs 1,551 crore. The price ...